Skip to content
Brand AI

Mayne Pharma

Recent events

Recent events tied to this brand in public sources.

Back to profile2 entries

  1. 2020

    FDA approves Mayne Pharma chlorzoxazone tablets

    The US Food and Drug Administration granted approval of Mayne Pharma's ANDA for chlorzoxazone tablets in 375 mg, 500 mg and 750 mg strengths.

    Source

  2. 2020

    Mayne Pharma launches BAC 300 capsules in the United States

    Mayne Pharma announced the launch in the United States of butalbital acetaminophen and caffeine capsules at 50mg/300mg/40mg.

    Source